The CB 1 cannabinoid receptor, the main target of Δ 9 -tetrahydrocannabinol (THC), the most prominent psychoactive compound of marijuana, plays a crucial regulatory role in brain development as evidenced by the neurodevelopmental consequences of its manipulation in animal models. Likewise, recreational cannabis use during pregnancy affects brain structure and function of the progeny. However, the precise neurobiological substrates underlying the consequences of prenatal THC exposure remain unknown. As CB 1 signaling is known to modulate long-range corticofugal connectivity, we analyzed the impact of THC exposure on cortical projection neuron development. THC administration to pregnant mice in a restricted time window interfered with subcerebral projection neuron generation, thereby altering corticospinal connectivity, and produced long-lasting alterations in the fine motor performance of the adult offspring. Consequences of THC exposure were reminiscent of those elicited by CB 1 receptor genetic ablation, and CB 1 -null mice were resistant to THC-induced alterations. The identity of embryonic THC neuronal targets was determined by a Cre-mediated, lineage-specific, CB 1 expression-rescue strategy in a CB 1 -null background. Early and selective CB 1 reexpression in dorsal telencephalic glutamatergic neurons but not forebrain GABAergic neurons rescued the deficits in corticospinal motor neuron development of CB 1 -null mice and restored susceptibility to THC-induced motor alterations. In addition, THC administration induced an increase in seizure susceptibility that was mediated by its interference with CB 1 -dependent regulation of both glutamatergic and GABAergic neuron development. These findings demonstrate that prenatal exposure to THC has long-lasting deleterious consequences in the adult offspring solely mediated by its ability to disrupt the neurodevelopmental role of CB 1 signaling.
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cannabis | CB 1 cannabinoid receptor | corticospinal | neurodevelopment | seizures R ecreational cannabis consumption during pregnancy can exert deleterious consequences in the progeny, including anxiety, depression, psychosis risk, and cognitive and social impairments (1, 2) . In the last two decades, important advances in our understanding of the endocannabinoid system have paved the way to elucidate the particular neurobiological substrates responsible for some cannabinoid-induced neurological alterations in adult animals and humans (3) . The currently accepted scenario is that the CB 1 cannabinoid receptor (CB 1 R), the main target of marijuana-derived cannabinoids, is located presynaptically and, upon engagement by endocannabinoids [2-arachidonoylglycerol (2-AG) and anandamide], can act as a key neuromodulatory and plasticity-tuning signaling platform at many different mature synapses (4) . In fact, CB 1 R constitutes one of the most abundant and functionally relevant G proteincoupled receptors in several regions of the adult mammalian brain (3, 4).
Manipulation of CB 1 R function in animal models, either directly or indirectly, by modulating 2-AG or anandamide levels through the main endocannabinoid-synthesizing [diacylglycerol lipase (DAGL) α/β] or degrading enzymes [monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH)], influences key processes of forebrain development, including (i) progenitor cell expansion and neurogenesis, (ii) neuronal and glial specification, and (iii) axonal pathfinding (5-7). Alterations of these developmental processes may conceivably underlie the functional deficits observed in the offspring upon prenatal exposure to THC. A crucial role has been assigned to CB 1 R in the development of long-range axonal connectivity by regulating corticofugal axon navigation and fasciculation (8, 9) . In particular, CB 1 R is essential for subcerebral projection neuron development, as it regulates the appropriate balance between the transcription factors Ctip2 and Satb2 (10), which is responsible for corticospinal motor neuron (CSMN) specification (11) .
In this study, we modeled prenatal cannabis consumption in mice to identify the particular neurodevelopmental substrates responsible for cannabinoid-induced functional alterations that Significance Marijuana is the most commonly used illicit drug, and its consumption constitutes a serious health concern. The psychoactivity of the plant is exerted by its cannabinoid constituents, especially Δ 9 -tetrahydrocannabinol (THC), which acts by engaging CB 1 cannabinoid receptors. Despite the large knowledge accumulated on how THC affects the adult brain, its molecular and functional impact on neuronal development remains obscure. This study demonstrates that remarkable detrimental consequences of embryonic THC exposure on adultbrain function, which are evident long after THC withdrawal, are solely due to the impact of THC on CB 1 receptors located on developing cortical neurons. Our findings thus delineate the risk of cannabis consumption during pregnancy and contribute to identify precise neuronal lineages targeted by prenatal THC exposure.
remain overt in adult animals. Administration of THC was conducted during a restricted embryonic time window, coinciding with the active period of glutamatergic neuron generation in the telencephalon (11) . To unequivocally assess the role of CB 1 R signaling in THC-induced alterations, we used CB 1 R-deficient mice, which were resistant to THC-induced developmental effects. Next, by using a Cre-mediated, lineage-specific, CB 1 R expression-rescue strategy in a CB 1 R-null background, we were able to selectively rescue the deficits in CSMN development of CB 1 R-deficient mice and, in turn, fully restore the susceptibility to THC-induced motor alterations in adulthood. We also found that embryonic THC exposure induced an increase in seizure susceptibility that was mediated by CB 1 R present in developing dorsal telencephalic pyramidal neurons and forebrain GABAergic neurons. Hence, targeting CB 1 R with the most prominent marijuana-derived psychoactive compound in a particular neuronal population and time frame during embryonic development can evoke remarkable longlasting neurological alterations.
Results
Prenatal THC Exposure Interferes with Cortical Projection Neuron Development. To investigate the impact of prenatal THC exposure on cortical development and to avoid the confounding influence that the cannabinoid could exert during very early gestational stages (12, 13), we administered one daily i.p. injection of THC or its vehicle to pregnant wild-type mice from E12.5 to E16.5. To minimize potential CB 1 R off-targets, a low dose of THC (3 mg/kg) was used. Of note, maternal and neonate body weight was unaffected by THC treatment, thus indicating that the dose used did not induce deleterious effects on general physical status. As the CB 1 R is essential for CSMN specification (10), the effects of embryonic THC exposure on the developing cortex were first assessed by quantifying the generation of subcerebral projection neurons. Confocal immunofluorescence analysis of Ets-related protein 81 (ER81), a bona fide marker of subcerebral projection neurons (11) , was performed in the treated offspring at P20. ER81 + neurons were decreased in THC-exposed animals compared with their vehicle-treated controls ( Fig. 1 A and B) . The impact of THC on CSMN development was also analyzed at the level of corticospinal axon projections. For this purpose, we performed fluorescent retrograde labeling (Red RetroBeads) from the cervical spinal cord to unequivocally identify CSMNs (14) (Fig. 1C) . Red-labeled somata in deep cortical layer V were shown to express ER81, thus confirming the validity of ER81 as an appropriate marker of CSMNs (Fig. 1D) . We also found a significant reduction in the number of labeled CSMN somata in THC-treated mice compared with their controls, pointing to an alteration of CSMN development and subcerebral connectivity ( Fig. 1 E and F) .
Prenatal THC Exposure Induces Long-Lasting Alterations in Skilled
Motor Function and Seizure Susceptibility. To examine the functional consequences of the impaired subcerebral projection neuron development induced by prenatal cannabinoid exposure, we first used the skilled reaching test, which allows the dissection of CSMN-dependent motor function as reflected by the ability to retrieve a pellet of palatable food with a forelimb through a narrow slit (15) . To rule out potential unspecific developmental alterations in the offspring owing to maternal care induced by THC administration (16), we used CB 1 −/− females, devoid of the behavioral impact of THC, which were mated with heterozygous CB 1 +/− males. Therefore, we analyzed skilled motor function in the CB 1 +/− and CB 1 −/− offspring. CB 1 +/− mice have been shown to exhibit an increased efficacy of agonist-induced G protein-coupled receptor signaling, which becomes comparable to that of wild-type CB 1 +/+ mice, thus supporting the validity of this experimental approach (17) . THC-exposed CB 1 +/− animals showed a significant impairment in skilled motor function compared with their vehicletreated counterparts ( Fig. 2A) . Remarkably, CB 1 −/− mice, which consistently with our previous report showed an impairment in this task compared with their vehicle-treated CB 1 +/− littermates (10), did not suffer from any worsening in their skilled motor performance upon THC exposure ( Fig. 2A) . Importantly, neither the number of trials (Fig. 2B ) nor the success in unskilled conditions was changed among groups, ruling out generalized motivational or unspecific motor alterations in the observed skilled motor deficits. Corticospinal function was also assessed with the staircase test, and again, a decreased performance was evident in THC-exposed CB 1 +/− mice compared with their vehicle-treated controls (Fig.  2C ). In addition, CB 1 −/− control mice performed worse than their CB 1 +/− littermates, and THC treatment did not significantly worsen their ability to reach the pellets. Control quantifications of unskilled reaching did not show significant differences among groups (Fig. 2D) . Altogether, these data demonstrate the CB 1 R dependency of embryonic THC-evoked motor alterations.
Developmental THC administration induces alterations in synaptic connectivity and plasticity (18, 19) , but its long-lasting functional consequences remain largely unknown. Therefore, we analyzed whether seizure susceptibility was affected in the adult offspring of THC-administered pregnant mice by using a pentylenetetrazole (PTZ) administration paradigm. Of note, latency to seizures was significantly decreased in prenatally THC-exposed CB 1 +/− mice compared with their vehicle-treated counterparts ( Fig. 2E ; 31.8 ± 1.4 and 37.0 ± 1.3 min, respectively; P < 0.01). Consequently, a reduced PTZ cumulative dose was required to induce generalized seizures in the THC-treated offspring ( Fig. 2F ; THC vs. vehicle, 81.3 ± 4.1 and 96.0 ± 3.5 mg/kg, respectively; P < 0.01). This effect of prenatal cannabinoid administration was reminiscent of the adult CB 1 −/− mice phenotype, which displays increased seizure susceptibility in the kainic acid model (20, 21) . Importantly, we found no further enhancement of PTZ susceptibility in THC-treated CB 1 −/− mice with respect to their vehicletreated counterparts, thus confirming the CB 1 R specificity of THC action ( Fig. 2F ; THC vs. vehicle, 30.2 ± 0.7 and 30.1 ± 1.0 min, respectively). Overall, the neuronal and functional analyses of prenatally THC-administered mice showed a similar phenotype to CB 1 R-null mice, thus indicating that embryonic THC exposure interferes with the neurodevelopmental role of CB 1 R signaling.
Prenatal THC Exposure Transiently Impairs CB 1 R Signaling. We next analyzed the consequences of prenatal THC administration on CB 1 R expression. CB 1 R protein levels, as determined by Western blot, were significantly down regulated in THC-treated embryonic brains at E17.5 compared with controls ( Fig. 3 A and C) . Notably, at a perinatal stage (P2.5), CB 1 R levels returned to those of the vehicle condition ( Fig. 3 B and D) , indicating that CB 1 Rs are altered only transiently in our embryonic THC-exposure paradigm. The presence of functional plasma membrane-exposed CB 1 R was next analyzed by the binding of the radioactively labeled CB 1 R agonist [ 3 H]CP-55,940. A reduced cannabinoid binding was observed in the brains of THC-treated embryos at E17.5 (Fig. 3 E  and G) , and its values recovered to the level of vehicle-treated animals at P2.5 ( Fig. 3 F and H) . Overall, these findings support that embryonic THC administration transiently disrupts appropriate CB 1 R function in the developing brain.
Neuronal Lineage-Specific CB 1 R Reexpression Selectively Rescues the Behavioral Traits of Embryonic THC Exposure. To unequivocally determine the neuronal identity of embryonic THC-exposure actions, we made use of a Cre-mediated, lineage-specific, embryonic CB 1 R expression-rescue strategy in a CB 1 R-null background (Stop-CB 1 mice) (21) . The selective expression of CB 1 R in dorsal telencephalic glutamatergic neurons (Glu-CB 1 -RS mice) was achieved by expressing Cre under the regulatory elements of the Nex gene (21) . In addition, we rescued CB 1 R expression in forebrain GABAergic neurons (GABA-CB 1 -RS mice) by using the Dlx5/6-Cre mouse line (20) . As a control, a global CB 1 R expression (E and F) THC-and vehicle-treated CB 1 +/− and CB 1 −/− mice were subjected to a PTZ administration paradigm. Latency to tonic-clonic seizure appearance after the first PTZ injection (E) and the cumulative dose of PTZ required (F) were calculated [n = 15 and 18 (CB 1 +/− vehicle-and THC-treated mice, respectively); n = 13 and 11 (CB 1 −/− vehicle-and THC-treated mice, respectively)]. *P < 0.05, **P < 0.01 vs. vehicle-treated CB 1 +/− mice. rescue approach driven by EIIa-Cre (CB 1 -RS) was also used (21) . Characterization of CB 1 R expression by immunofluorescence was performed in the different mouse lines. In a Stop-CB 1 mice-only background, a nonspecific signal was detected, whereas in Glu-CB 1 -RS and GABA-CB 1 -RS animals, CB 1 R immunoreactivity was observed with a distinctive pattern of expression (Fig. 4 A-C) . Glu-CB 1 -RS mice at P2.5 revealed a significant CB 1 R expression in descending corticofugal axons, whereas in GABA-CB 1 -RS mice a prominent CB 1 R expression was observed in the immature hippocampal formation (Fig. 4 A, A1-A4 ). Cortical CB 1 R expression at P20 in Glu-CB 1 -RS mice appeared as scarce immunopositive puncta, in agreement with the low expression of the receptor in mature projection neurons (4), whereas most CB 1 R expression corresponded to GABAergic neurons (Fig. 4 B, B1-B4 ). Double immunofluorescence with VGLUT1 and VGAT, presynaptic markers of glutamatergic and GABAergic terminals, respectively, confirmed the selectivity of the CB 1 R expression-rescue strategy (Fig. 4C) . Thus, in Glu-CB 1 -RS mice, the small puncta of CB 1 R did not colocalize with VGAT immunoreactivity, in agreement with their presynaptic location in glutamatergic neurons (Fig. 4C) .
To assess the reestablishment of the neurobiological substrate of THC-induced alterations, we quantified the number of ER81-positive cells in cortical layer V. Remarkably, in vehicle-treated Glu-CB 1 -RS mice, the number of deep-layer ER81-positive cells per cortical column was significantly rescued compared with Stop-CB 1 animals (96.8 ± 6.6 and 71.7 ± 4.9, respectively; P < 0.05), and in concert, Glu-CB 1 -RS mice gained susceptibility to THC-induced impairment of subcerebral projection-neuron development (73.2 ± 5.5; P < 0.05 vs. vehicle-treated Glu-CB 1 -RS mice).
Once the lineage selectivity of the CB 1 R expression-rescue strategy at the cellular level was proved, we investigated the functional impact of embryonic THC exposure in adulthood. THC or vehicle was administered to pregnant mice coming from crosses of Stop-CB 1 with Nex-Cre (Glu-CB 1 -RS) or Dlx5/6-Cre (GABA-CB 1 -RS) animals, and their respective offspring were analyzed at an adult age. CB 1 R reexpression in Glu-CB 1 -RS mice, but not in GABA-CB 1 -RS mice, rescued the skilled motor deficits of Stop-CB 1 mice as assessed by both the skilled-reaching test (Fig. 5A ) and the staircase test (Fig. 5B) . Global rescue of CB 1 R expression in CB 1 -RS mice also abolished the skilled motor deficits observed in Stop-CB 1 mice. Overall, CB 1 R expression rescue in dorsal telencephalic glutamatergic neurons is necessary and sufficient to confer THC susceptibility to corticospinal motor function.
Finally, we also analyzed PTZ-induced seizure susceptibility in the various CB 1 R expression-rescued mice. Stop-CB 1 mice showed a seizure-prone phenotype that was fully restored when the CB 1 R was expressed systemically in CB 1 -RS mice, whereas seizure susceptibility was partially restored in both Glu-CB 1 -RS and GABA-CB 1 -RS (Fig. 5 C and D; latency to seizures in THCtreated mice, Glu-CB 1 -RS vs. CB 1 -RS, 34.0 ± 5.0 and 42.7 ± 2.2 min, respectively, P < 0.05; GABA-CB 1 -RS vs. CB 1 -RS, 33.6 ± 2.2 and 42.7 ± 2.2 min, respectively, P < 0.05; cumulative PTZ dose, Glu-CB 1 -RS vs. CB 1 -RS, 90.0 ± 10 and 106.6 ± 5.1 mg/kg, respectively, P < 0.05; GABA-CB 1 -RS vs. CB 1 -RS, 87.2 ± 6.6 mg/kg and 106.6 ± 5.1 mg/kg, respectively, P < 0.01). Notably, upon THC administration, only CB 1 -RS mice showed increases in seizure latency and PTZ cumulative dose, whereas no significant differences were found among Stop-CB 1 , Glu-CB 1 -RS, and GABA-CB 1 -RS mice (Fig. 5 C and D) . These findings support the notion that prenatal CB 1 R signaling in both glutamatergic and GABAergic cell lineages is required for the appropriate balance of neuronal activity.
Discussion
The present study reveals that embryonic THC exposure exerts long-lasting consequences in the offspring owing to a transient disruption of CB 1 R signaling that impedes the adequate temporally and spatially confined function of the receptor in cortical neuron development. Remarkably, the deleterious consequences of prenatal THC exposure in the progeny are independent of the classical neuromodulatory role of CB 1 R signaling in the adult brain and emerge exclusively as a consequence of the transient disruption of physiological CB 1 R signaling during prenatal development, when synaptic neuronal activity is not yet established. These findings provide previously unidentified preclinical evidence for the risk of cannabis consumption during pregnancy. Cannabis is, by far, the most commonly consumed illicit drug during pregnancy in Western countries, and therefore its use Immunofluorescence analysis of CB 1 R reexpression driven by Nex (Glu-CB 1 -RS) (A3), Dlx5/6 (GABA-CB 1 -RS) (A4), or EIIa (CB 1 -RS) (A2) promoters in Stop-CB 1 mice (A1) was performed in P2.5 coronal brain sections. (B) Cortical CB 1 R expression analysis in the same mouse strains was performed at P20 (B1-B4). (C) Double immunofluorescence was performed with anti-CB 1 antibody combined with anti-VGLUT1 (C1-C4) or anti-VGAT (C1'-C4') antibodies. Arrowheads point to the glutamatergic CB 1 R signal, which is abundant in pyramidal neuron fibers at P2.5 (A) and to scarce immunopositive puncta corresponding to glutamatergic (VGLUT1-positive) terminals at P20 (B and C). Arrows point to the abundant CB 1 R signal corresponding to GABAergic (VGAT-positive) neurons within the hippocampal formation at P2.5 (A) and the mature cortex at P20 (B and C). constitutes a considerable public health issue (1, 2, 16) . Over the last few decades, longitudinal studies on human cohorts (1, 2), as well as research using animal models (22) , have addressed the impact of early cannabinoid exposure in adulthood. The majority of these studies suggest that early cannabinoid exposure sensitizes the CNS to cognitive impairments, increases the risk of neuropsychiatric disorders such as schizophrenia and anxiety, induces motor alterations, and enhances drug-addiction susceptibility (23) (24) (25) . Our findings show that exposure to low doses of THC in a narrow temporal window during prenatal development negatively impacts mouse cortical development, and this, in turn, has longterm functional consequences on the mature offspring. Specifically, we unequivocally identify the pool of CB 1 R located on developing cortical glutamatergic neurons as the sole reason for the deficits in corticospinal function induced by embryonic THC exposure.
The CB 1 R plays a pivotal neurodevelopmental role by transducing information from the endocannabinoid ligands present in the neurogenic niche into the coordination of the intrinsic developmental program of developing neurons (6, 26) . In agreement, early developmental exposure of chicken embryos to a THC analog (27) and genetic manipulation of the CB 1 R-interacting protein CRIP1 (28) have been shown to disrupt the appropriate balance of transcription factors that intrinsically drive neuronal development. Thus, CB 1 R signaling refines the molecular, laminar, and hodological identity of projection neurons in the pre-and postnatal cerebral cortex (5, 6) . The present findings support that THC can act as a functional suppressor of CB 1 R signaling, as restricted exposure to THC interferes with developmental CB 1 R function in a transient but functionally impacting manner. Therefore, prenatal cannabinoid exposure recapitulates the long-term structural and functional deficits in corticospinal connectivity previously demonstrated in CB 1 Rknockout mice (10) . The susceptibility of axonal connectivity to embryonic CB 1 R loss of function (present report) may persist at later developmental stages in critically susceptible areas, as it has been demonstrated that THC consumption in adolescents can also result in axonal connectivity deficits (29) . Nevertheless, in another study, daily marijuana consumption did not induce volumetric changes in several brain areas (30) .
Our findings are in partial agreement with a previous study reporting that chronic prenatal THC administration alters neuronal connectivity by disrupting cytoskeletal dynamics in motile axons. Specifically, prolonged THC administration (E5.5 to E17.5) was shown to disrupt cannabinoid signaling by interfering with 2-AG-metabolizing enzymes, MAGL, and DAGL, but did not induce CB 1 R desensitization (18) . In that study, the functional consequences of chronic prenatal THC administration on axonal projections were not determined. Manipulation of endocannabinoid levels in perinatal stages by chronic pharmacological inhibition of FAAH, the main anandamide-degrading enzyme, induced depressive and cognitive impairment traits, despite the fact that no specific neuronal development alterations could be demonstrated (9) . On the other hand, pharmacological inhibition of MAGL increased 2-AG levels and induced axon fasciculation alterations by interfering with Slit2/Robo1 signaling, but the functional consequences of these actions remain unknown (31) . Other studies have also shown that perinatal cannabinoid administration induces cognitive deficits that can be linked to neuronal transmission adaptations, particularly plasticity of glutamatergic neuron activity (19, 25, 32, 33) and aberrant synaptic organization (18, 34) . In humans, prenatal cannabis exposure interferes with executive function (2) and increases children's depressive symptoms when excluding identified covariate factors such as maternal tobacco use, education, and child composite IQ (35) . Moreover, prenatal cannabis exposure interferes with prefrontal cortex-mediated response inhibition as revealed by functional MRI, which may reflect delayed cortical maturation (36) . Thus, whereas it is already known that postnatal cannabinoid exposure has negative consequences on neurological functions in the adult brain (1), this study unveils long-lasting functional neuronal alterations induced by restricted prenatal cannabinoid administration that can be unequivocally ascribed to specific developing neuronal lineages. Notably, our findings reveal a direct impact of THC exposure on the developing embryo that does not rely on indirect consequences of maternal programming and that is evident without the requirement of a second hit, as proposed for cannabis-induced risk of psychosis (16) . In any case, translating the long-term implications of developmental cannabis exposure into humans requires a very stringent control of confounding factors (37, 38) , and this is more important when analyzing cognitive and psychiatric traits than merely determining plastic adaptations of neuronal activity or drug abuse sensitivity.
In addition to corticospinal motor function alterations, embryonic THC exposure increased seizure susceptibility in adult mice, even when CB 1 Rs return to normal levels shortly after cessation of THC exposure. The neuromodulatory role of CB 1 R in the mature brain exerts overall an anticonvulsant action (4). In addition, great interest has recently emerged in the potential application of cannabis preparations enriched in cannabidiol for the management of pediatric epilepsy disorders such as Dravet and Gaston-Leroux syndromes (39) . However, results presented herein demonstrate that THC interferes with the developmental role of CB 1 R signaling and induces a proepileptogenic neural ; n = 9 and 5 (Glu-CB 1 -RS vehicle-and THC-treated mice, respectively); n = 9 and 8 (GABA-CB 1 -RS vehicle-and THC-treated mice, respectively)]. *P < 0.05, **P < 0.01 vs. corresponding Stop-CB 1 mice; # P < 0.05, circuitry configuration independently of its neuromodulatory role in the adult brain. Our CB 1 R expression-rescue experiments show that the THC-induced increase in PTZ-evoked seizure susceptibility relies on alterations not only of projection neurons but also of GABAergic neurons. Further investigations are required to underscore the potential contribution of these and perhaps other neuronal lineages targeted by prenatal cannabinoid exposure. In any event, our preclinical observations support that although cannabis preparations can exert anticonvulsive actions in children and adults, they can also enhance the risk of seizures by suppressing CB 1 R signaling in the developing brain, thus raising a note of caution that might be considered when the potential therapeutic uses of cannabinoid-based medicines are defined and regulated for pregnant women.
Materials and Methods
THC Administration. Ultrapure THC (≥99% HPLC; THC Pharm) was administered i.p. to pregnant female mice at a final dose of 3 mg/kg for 5 consecutive days from E12.5 to E16.5.
Cellular Analyses and Behavioral Determinations. CSMN immunofluorescence and retrograde labeling analyses were performed at P20. Skilled motor function (skilled-reaching and staircase) tests were carried out in 2-month-old mice prenatally exposed to THC or its vehicle. Seizure susceptibility was assessed by injecting PTZ (22.5 mg/kg) every 10 min until generalized seizures occurred.
CB 1 R Biochemical Characterization. CB 1 R levels were analyzed by Western blot as well as binding of radiolabeled CP-55,940 in E17.5-and P2.5-treated brain samples.
Genetic CB 1 R Rescue. CB 1 R expression rescue was performed in Stop-CB 1 mice by using Nex-Cre, Dlx5/6-Cre, and EIIa-Cre-driven recombination (20, 21) . Immunohistological characterization of different CB 1 R-rescue mice was performed in P2.5 and P20 brain samples. Corticospinal motor function as well as seizure susceptibility were assessed in THC-and vehicle-treated 2-month-old CB 1 R-rescue mice.
Animals. Experimental designs and procedures were approved by the Complutense University Animal Research Committee in accordance with the European Commission regulations. All efforts were made to minimize the number of animals and their suffering throughout the experiments. Additional experimental procedures are described in SI Materials and Methods.
